Antifungal (undecylenic acid)
Last reviewed · Source: First Databank (FDB) drug data
Overview
Undecylenic acid and undecylenate salts are antifungal agents.
Undecylenic acid and undecylenate salts (e.g., calcium undecylenate, copper undecylenate, zinc undecylenate) are topical antifungal agents. The drugs usually are used in combination, with the combined potency labeled in terms of total undecylenate, although they also can be used individually as antifungal agents. The combination containing zinc undecylenate and undecylenic acid is sometimes referred to as zincundecate.
The drugs are used topically in the treatment of athlete's foot (tinea pedis), jock itch (tinea cruris), and other skin infections caused by dermatophytic fungi (ringworm).
Generic name: undecylenic acid
Pronunciation: (un-de-sil-EN-ik)
Reference product & biosimilars
No reference, biosimilar or interchangeable associated with this drug.
Today’s intelligence on Antifungal
Indications
The following indications are listed for Antifungal:
- Dermatophytosis
- Tinea Corporis
- Tinea Pedis
Also known as: Corporeal Ringworm, Dermatomycosis Pedis, Tinea, Tinea Circinata, Tinea Glabrosa, Tinea Infection, Tinea Of The Foot.
Dosing
Undecylenic acid and undecylenate salts are used individually or in combination in total concentrations of 10-25%. Preparations containing the drugs are applied topically twice daily after cleansing the affected area. The ointment should be used at night. Treatment should usually be continued for 4 weeks when treating athlete's foot or ringworm and for 2 weeks when treating jock itch. Preparations containing the drugs are not effective in the treatment of fungal infections of the scalp or nails.
The American Society of Health-System Pharmacists, Inc. represents that the information provided in the accompanying monograph was formulated with a reasonable standard of care, and in conformity with professional standards in the field. Readers are advised that decisions regarding use of drugs are complex medical decisions requiring the independent, informed decision of an appropriate health care professional, and that the information contained in the monograph is provided for informational purposes only. The manufacturer's labeling should be consulted for more detailed information. The American Society of Health-System Pharmacists, Inc. does not endorse or recommend the use of any drug. The information contained in the monograph is not a substitute for medical care.
No dosing information is available for this tab.
No dosing information is available for this tab.
No dosing information is available for this tab.
Drug interactions
There is no enhanced messaging for this drug.
There are no contraindication interactions for this drug.
There are no severe interactions for this drug.
There are no moderate interactions for this drug.
Contraindications
There is no enhanced messaging for this drug.
There are no contraindication contraindications for this drug.
There are no severe contraindications for this drug.
There are no moderate contraindications for this drug.
Adverse reactions
There is no enhanced messaging for this drug.
There are no severe adverse reactions for this drug.
There are no less severe adverse reactions for this drug.
Precautions
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
ICD codes
No ICD codes are available for this drug.
Formulary status
Search health-plan coverage for this drug by ZIP code.
Choose the first character of a health plan name.
Last reviewed · Source: First Databank (FDB) drug data
On this page
Actions
Sign in to save favorites
Saving this drug requires a free Physicians Office Resource account.